The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school‐age subjects

@article{Catassi1996TheCI,
  title={The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school‐age subjects},
  author={Carlo Catassi and Elisabetta Fabiani and I. M. R{\"a}tsch and G. V. Coppa and PL Giorgi and Rossella Pierdomenico and Susanna Alessandrini and G. Iwanejko and Raffaele Domenici and E Mei and Angelo Miano and Miris Marani and Giuseppe Bottaro and Massimo Spina and Maria Dotti and Alessandro Montanelli and Maria Barbato and Franca Viola and Rosanna Lazzari and M Vallini and Graziella Guariso and Mario Plebani and Francesco Cataldo and G. B. Traverso and Claudio Ughi and G Chiaravalloti and Mariella Baldassarre and P Scarcella and F Bascietto and Letizia Ceglie and A. Valenti and Paolo Paolucci and M. Caradonna and Enzo Bravi and Alessandro Ventura},
  journal={Acta P{\ae}diatrica},
  year={1996},
  volume={85}
}
Background: Recent studies suggest that coeliac disease (CD) is one of the commonest, life‐long disorders in Italy. The aims of this multicentre work were: (a) to establish the prevalence of CD on a nationwide basis; and (b) to characterize the CD clinical spectrum in Italy. Patients and methods: Fifteen centres screened 17201 students aged 6–15 years (68.6% of the eligible population) by the combined determination of serum IgG‐ and IgA‐antigliadin antibody (AGA) test; 1289 (7.5%) were IgG and… 

Population screening for coeliac disease in a low prevalence area in Italy

TLDR
The results suggest that the low prevalence of CD observed in some regions is likely to be due to underdiagnosis.

Antiendomysium versus Antigliadin Antibodies in Screening the General Population for Coeliac Disease

TLDR
The EMA protocol is superior to the AGA protocol for mass screening of coeliac disease because of higher sensitivity, decreased need for intestinal biopsy, and possibility to detect potential cases of coediac disease.

Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease.

TLDR
The EMA protocol is superior to the AGA protocol for mass screening of coeliac disease because of higher sensitivity, decreased need for intestinal biopsy, and possibility to detect potential cases of coediac disease.

Prevalence of coeliac disease in the adult population of central Greece

TLDR
This first serological screening study for CD in Greece has demonstrated that CD prevalence in Thessaly is among the lowest reported in Europe.

The Celiac Iceberg: Characterization of the Disease in Primary Schoolchildren

TLDR
It is demonstrated that CD prevalence is growing in Italy, with a modified clinical spectrum and iceberg deepness, according to primary schoolchildren of this region.

Prevalence of celiac disease among blood donors in Brazil

TLDR
The preliminary results support the view that CD is not a rare disease in Brazil, with a prevalence of undiagnosed CD of 1:681 among apparently healthy blood donors.

[Silent celiac disease: exploring the iceberg in the school-aged population].

TLDR
The high prevalence of silent celiac disease among the school-aged population is confirmed and could be due to a high diagnostic suspicion for CD among pediatricians in the health district IX in Madrid.

The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project

TLDR
Investigating whether the prevalence of CD significantly varies between different areas of the European continent finds large unexplained differences in adult age across different European countries.

How frequent is coeliac disease in Down syndrome?

TLDR
The prevalence of coeliac disease in DS was investigated using gliadin and endomysium antibodies as screening tools and small intestinal biopsy for definitive diagnosis and a very high prevalence of AGA positivity showed.
...

References

SHOWING 1-10 OF 29 REFERENCES

Anti‐endomysium and anti‐gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine

TLDR
To avoid unnecessary biopsy before mucosal relapse can be demonstrated during gluten challenge in a child without clinical symptoms, it is suggested that the tests are used as serial testing, i.e. a biopsy should be performed if both tests are positive.

Serological screening suggests that adult coeliac disease is underdiagnosed in the UK and increases the incidence by up to 12%.

TLDR
R1-ARA, even in the absence of the expected symptoms and signs of coeliac disease, is an indication for jejunal biopsy and is a reliable indicator of occult coeliat disease.

Antigliadin and antiendomysium antibody determination for coeliac disease.

TLDR
Patients who are young at diagnosis of coeliac disease and without a morphological relapse were less than 2 years old at diagnosis so it is concluded that patients who areYoung at diagnosis should be challenged.

Changes in coeliac disease behaviour over the years

TLDR
It is concluded that in Sicily, in recent years, the incidence of coeliac disease has been increasing, with onset within the 2nd year of life, and chronic diarrhoea, growth failure and abdominal distention as key symptoms.

High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies.

TLDR
In the present study, a high IgA antigliadin activity had a positive predictive value between 18% and 25% in individuals without symptoms indicative of celiac disease depending on the way the cut-off points were chosen.

Different features of coeliac disease in two neighbouring countries.

TLDR
It is concluded that the intake of infant cereal protein might influence when and how clinical coeliac disease appears.

Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis.

TLDR
Patients who had a gluten-free diet for a period during childhood; patients with short stature, anemia, or amenorrhea of no obvious cause; or patients with unexplained immunological abnormalities are the groups in which most patients with subclinical celiac sprue have been found and in which potential patients should be sought.

IgA anti‐endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease

TLDR
The presence and the titre of IgA‐EmA and AGA paralleled the severity of the jejunal changes in patients with coeliac disease.